quinapril has been researched along with Disease Exacerbation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulton-Jones, JM; Deighan, CJ; MacGregor, MS; Rodger, RS | 1 |
| Barnes, T; Black, CM; Camilleri, J; Chakravarty, K; Denton, CP; Doré, CJ; Emery, P; Gliddon, AE; Griffiths, B; Herrick, A; Hickling, P; Hopkinson, ND; Lanyon, P; Laversuch, C; Lawson, T; Maddison, PJ; Mallya, R; McHugh, N; Moots, R; Nisar, M; Rhys-Dillon, C; Sheeran, T | 1 |
| Malik, RA | 1 |
| Bass, T; Cashin-Hemphill, L; Feldman, R; Ferrari, R; Haber, H; Lees, RS; Mudra, H; O'Neill, B; Pepine, C; Pitt, B; Schwartz, L; Texter, M; Uprichard, A | 1 |
| Aizawa, Y; Fuse, K; Hanawa, H; Inoue, M; Kodama, M; Kouda, T; Ma, M; Nakazawa, M; Ohta, Y; Sekiguchi, T; Wahed, MI; Watanabe, K; Yamamoto, T; Yoshida, Y | 1 |
1 review(s) available for quinapril and Disease Exacerbation
| Article | Year |
|---|---|
Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Diabetic Neuropathies; Disease Progression; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 2000 |
3 trial(s) available for quinapril and Disease Exacerbation
| Article | Year |
|---|---|
A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failure.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Quinapril; Tetrahydroisoquinolines | 2005 |
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Quinapril; Raynaud Disease; Scleroderma, Limited; Tetrahydroisoquinolines; Treatment Outcome | 2007 |
The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.
Topics: Adult; Aged; Angioplasty; Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Humans; Incidence; Isoquinolines; Male; Middle Aged; Myocardial Ischemia; Proportional Hazards Models; Quinapril; Survival Analysis; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Function, Left | 2001 |
1 other study(ies) available for quinapril and Disease Exacerbation
| Article | Year |
|---|---|
Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Heart Failure; Isoquinolines; Male; Myocarditis; Quinapril; Rats; Rats, Inbred Lew; RNA, Messenger; Tetrahydroisoquinolines; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |